Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GENFIT
  6. News
  7. Summary
    GNFT   FR0004163111

GENFIT

(GNFT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Tuesday Trading

08/31/2021 | 01:29pm EST


ę MT Newswires 2021
All news about GENFIT
12/01European ADRs Move Sharply Higher in Wednesday Trading
MT
11/19European ADRs Move Sharply Lower in Friday Trading
MT
11/19GLOBAL MARKETS LIVE : Alibaba, Applied Materials, Ryanair, Unilever, Apple....
11/18GENFIT : FNIH NIMBLE Study Demonstrates NIS4« Technology's Unique Performance in Identifyi..
PU
11/18GENFIT : FNIH NIMBLE Study Demonstrates NIS4« Technology's Unique Performance in Identifyi..
AQ
11/18Genfit SA's FNIH NIMBLE Study Demonstrates NIS4? Technology?s Unique Performance in Ide..
CI
11/10Genfit Hepatic Impairment Drug Study Completes First Patient Visit
MT
11/09GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with H..
PU
11/09GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with H..
AQ
11/09GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with H..
CI
More news
Analyst Recommendations on GENFIT
More recommendations
Financials
Sales 2021 7,50 M 8,49 M 8,49 M
Net income 2021 -47,9 M -54,2 M -54,2 M
Net Debt 2021 87,0 M 98,4 M 98,4 M
P/E ratio 2021 -1,84x
Yield 2021 -
Capitalization 133 M 150 M 150 M
EV / Sales 2021 29,3x
EV / Sales 2022 19,6x
Nbr of Employees 122
Free-Float 94,4%
Chart GENFIT
Duration : Period :
GENFIT Technical Analysis Chart | GNFT | FR0004163111 | MarketScreener
Technical analysis trends GENFIT
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 2,91 €
Average target price 9,50 €
Spread / Average Target 227%
EPS Revisions
Managers and Directors
Pascal Prigent CEO & EVP-Marketing & Development
Thomas Baetz Chief Financial Officer
Jean-Franšois Mouney Chairman
Carol L. Addy Chief Medical Officer
Dean W. Hum Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
GENFIT-26.60%150
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298